8.78
price up icon4.28%   0.36
 
loading
前日終値:
$8.42
開ける:
$8.42
24時間の取引高:
315.16K
Relative Volume:
1.22
時価総額:
$406.60M
収益:
$2.22M
当期純損益:
$-40.51M
株価収益率:
-6.8343
EPS:
-1.2847
ネットキャッシュフロー:
$-46.53M
1週間 パフォーマンス:
+37.19%
1か月 パフォーマンス:
-11.04%
6か月 パフォーマンス:
-62.80%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$8.13
$8.92
1週間の範囲:
Value
$6.32
$8.92
52週間の値動き範囲:
Value
$5.14
$29.46

Upstream Bio Inc Stock (UPB) Company Profile

Name
名前
Upstream Bio Inc
Name
セクター
Healthcare (1151)
Name
電話
781-208-2466
Name
住所
890 WINTER STREET, SUITE 200, WALTHAM
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
UPB's Discussions on Twitter

UPB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
UPB
Upstream Bio Inc
8.78 406.60M 2.22M -40.51M -46.53M -1.2847
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Upstream Bio Inc Stock (UPB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-05 開始されました JP Morgan Overweight
2024-11-05 開始されました Piper Sandler Overweight
2024-11-05 開始されました TD Cowen Buy
2024-11-05 開始されました William Blair Outperform

Upstream Bio Inc (UPB) 最新ニュース

pulisher
Apr 17, 2025

Upstream Bio: Verekitug, A Longer-Acting Dupixent?Key Data Is Imminent - Seeking Alpha

Apr 17, 2025
pulisher
Apr 15, 2025

Corebridge Financial Inc. Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Upstream Bio (NASDAQ:UPB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 11, 2025
pulisher
Apr 10, 2025

Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Upstream's IPO Lockup Period Expires, RSLS Partners With Israel-based Motion, PVLA On Watch - RTTNews

Apr 10, 2025
pulisher
Apr 10, 2025

Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 10, 2025
pulisher
Apr 08, 2025

Certain Common Stock of Upstream Bio, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2025. - marketscreener.com

Apr 08, 2025
pulisher
Apr 02, 2025

Upstream Bio, Inc.’s Lock-Up Period Will Expire on April 9th (NASDAQ:UPB) - Defense World

Apr 02, 2025
pulisher
Mar 29, 2025

Charles Schwab Investment Management Inc. Invests $2.23 Million in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

Bank of New York Mellon Corp Invests $607,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Mar 27, 2025
pulisher
Mar 20, 2025

1,660 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by US Bancorp DE - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution - TipRanks

Mar 19, 2025
pulisher
Mar 15, 2025

William Blair Lifts Earnings Estimates for Upstream Bio - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

Long UPB: Upstream Bio’s Robust Financials and Clinical Progress Signal Bullish Reversal - Invezz

Mar 13, 2025
pulisher
Mar 13, 2025

Upstream Bio’s Financial Results and Strategic Progress - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

Promising Developments and Strong Financial Position Drive Buy Rating for Upstream Bio, Inc. - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Buy Rating for Upstream Bio: Promising Clinical Progress and Unique Drug Candidate Potential - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Form 10-K Upstream Bio, Inc. For: Dec 31 - StreetInsider.com

Mar 12, 2025
pulisher
Mar 12, 2025

Upstream Bio, Inc. Completes Enrollment in Phase 2 Trial of Verekitug for Chronic Rhinosinusitis and Raises $293 Million in IPO - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business ... - Enid News & Eagle

Mar 12, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Invests $275,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Mar 10, 2025
pulisher
Mar 03, 2025

AstraZeneca And GSK Put Spotlight On Nasal Polyps Space - Citeline News & Insights

Mar 03, 2025
pulisher
Feb 25, 2025

Upstream Bio to Present at Upcoming March Investor Conferences - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

Respiratory Disease Biotech Upstream Bio Schedules Two Major Investor Presentations in March - StockTitan

Feb 25, 2025
pulisher
Feb 22, 2025

Upstream Bio (UPB) Projected to Post Earnings on Thursday - Armenian Reporter

Feb 22, 2025
pulisher
Feb 20, 2025

Global Upstream Bioprocessing Equipment Market Poised for - GlobeNewswire

Feb 20, 2025
pulisher
Feb 17, 2025

Upstream Bioprocessing Market Size to Reach $105.46 Bn by 2034 - BioSpace

Feb 17, 2025
pulisher
Feb 17, 2025

Upstream Bio Inc (NASDAQ: UPB) – An Analysis Is What You Need - Stocks Register

Feb 17, 2025
pulisher
Feb 14, 2025

‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public - BioPharma Dive

Feb 14, 2025
pulisher
Feb 11, 2025

Critical Alert: Auto Industry Hit By Devastating Cyber Attacks60% Incidents Impact Millions - StockTitan

Feb 11, 2025
pulisher
Feb 08, 2025

Upstream Bio (NASDAQ:UPB) Reaches New 52-Week LowHere's Why - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Upstream Bio (NASDAQ:UPB) Trading Down 7.3%Here's What Happened - MarketBeat

Feb 06, 2025
pulisher
Feb 04, 2025

Severe Asthma FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight - The Globe and Mail

Feb 04, 2025
pulisher
Feb 04, 2025

Upstream Bio (NASDAQ:UPB) Trading 9.4% HigherStill a Buy? - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025
pulisher
Feb 03, 2025

Upstream Bio (UPB) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 03, 2025
pulisher
Feb 01, 2025

Moody Aldrich Partners LLC Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB) - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

Chronic Rhinosinusitis with Nasal Polyps Pipeline 2024: FDA - openPR

Jan 31, 2025
pulisher
Jan 27, 2025

Upstream Bio (NASDAQ:UPB) Sets New 52-Week Low – Time to Sell? - Defense World

Jan 27, 2025
pulisher
Jan 25, 2025

Upstream Bio (NASDAQ:UPB) Trading Down 3.9%Time to Sell? - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

Upstream Bio (NASDAQ:UPB) Sets New 52-Week LowTime to Sell? - MarketBeat

Jan 25, 2025

Upstream Bio Inc (UPB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Upstream Bio Inc (UPB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
ORBIMED ADVISORS LLC
Director
Oct 15 '24
Buy
17.00
825,000
14,025,000
4,554,873
AI Upstream LLC
10% Owner
Oct 15 '24
Buy
17.00
1,175,000
19,975,000
1,175,000
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):